Ribbon Bio’s Co-Founder & Head of Data Operations, Wladimir Labeikovsky, has co-authored a new op-ed in Science|Business alongside James Diggans, VP, Policy and Biosecurity, Twist Bioscience: “Viewpoint: A strong EU Biotech Act is vital for Europe’s synthetic-biology industry”.
The push for an EU Biotech Act highlights a core challenge for EU Innovation, balancing openness with safety. A single, harmonized framework for Synthetic Biology could reduce regulatory fragmentation, strengthen Biosecurity, and position Europe as a true global leader in the next wave of biotechnology.
